Systematic review / meta-analysis / 2013
Tomato and lycopene consumption showed nonsignificant trends toward lower prostate cancer risk.
A meta-analysis evaluated 11 cohort and six nested case-control studies examining tomato and lycopene intake and prostate cancer risk. Higher intake of raw tomatoes (OR = 0.81; 95% CI, 0.59-1.10) and cooked tomatoes (OR = 0.85; 95% CI, 0.69-1.06) was not significantly associated with prostate cancer incidence compared to lower intake. Similarly, higher lycopene intake (OR = 0.93; 95% CI, 0.86-1.01) and serum lycopene (OR = 0.97; 95% CI, 0.88-1.08) showed no statistically significant associations.
Shows an association, not proof of cause and effect.
- Study type
- Meta-analysis of prospective studies
- Who was studied
- 17 prospective studies (11 cohort, 6 nested case-control)
- What was measured
- Prostate cancer incidence
THE PAPER
Lycopene/tomato consumption and the risk of prostate cancer: a systematic review and meta-analysis of prospective studies.
Chen J, Song Y, Zhang L. J Nutr Sci Vitaminol (Tokyo), 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.